JAGSONPAL PHARMACEUTICALS
Back to Income Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹287 Cr | ₹269 Cr | ₹209 Cr | ₹237 Cr | ₹218 Cr |
What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹287 Cr |
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹209 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹218 Cr |
How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹287 Cr | 6.89 | |
| Mar2025 | ₹269 Cr | 28.76 | |
| Mar2024 | ₹209 Cr | -11.83 | |
| Mar2023 | ₹237 Cr | 8.79 | |
| Mar2022 | ₹218 Cr | - | |
Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,564.9 Cr | -2.8% | -1.6% | -0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -2.8% |
-1.6% |
-0.4% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses